Vicki Save

2.6k total citations
27 papers, 1.0k citations indexed

About

Vicki Save is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Vicki Save has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Vicki Save's work include Esophageal Cancer Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (6 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). Vicki Save is often cited by papers focused on Esophageal Cancer Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (6 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). Vicki Save collaborates with scholars based in United Kingdom, United States and Portugal. Vicki Save's co-authors include Rebecca C. Fitzgerald, Pierre Lao-Sirieix, Maria O’Donovan, Carlos Caldas, Peter A. Hall, Chunsheng Zhang, James S. Hardwick, Fátima Carneiro, Philip J. Coates and Jonathan Rees and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Vicki Save

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicki Save United Kingdom 14 480 413 386 254 231 27 1.0k
Matti Juhola Finland 17 565 1.2× 395 1.0× 300 0.8× 205 0.8× 246 1.1× 20 1.2k
Federico Buffoli Italy 19 618 1.3× 171 0.4× 532 1.4× 478 1.9× 148 0.6× 45 1.2k
Laura J. Prevo United States 7 912 1.9× 348 0.8× 569 1.5× 242 1.0× 151 0.7× 9 1.3k
Masaru Haraguchi Japan 17 304 0.6× 273 0.7× 397 1.0× 301 1.2× 143 0.6× 41 958
Makoto Eizuka Japan 16 224 0.5× 139 0.3× 290 0.8× 317 1.2× 127 0.5× 77 725
Takamitsu Kanazawa Japan 21 464 1.0× 289 0.7× 268 0.7× 711 2.8× 48 0.2× 45 1.2k
Angela N. Bartley United States 16 220 0.5× 208 0.5× 388 1.0× 605 2.4× 99 0.4× 27 1.1k
Julia Kitz Germany 22 313 0.7× 426 1.0× 280 0.7× 564 2.2× 77 0.3× 52 1.2k
Eiichi Tahara Japan 14 342 0.7× 399 1.0× 201 0.5× 334 1.3× 36 0.2× 14 976
Mirjam F. Mastik Netherlands 14 119 0.2× 233 0.6× 283 0.7× 175 0.7× 170 0.7× 28 656

Countries citing papers authored by Vicki Save

Since Specialization
Citations

This map shows the geographic impact of Vicki Save's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki Save with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki Save more than expected).

Fields of papers citing papers by Vicki Save

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki Save. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki Save. The network helps show where Vicki Save may publish in the future.

Co-authorship network of co-authors of Vicki Save

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki Save. A scholar is included among the top collaborators of Vicki Save based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki Save. Vicki Save is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
O’Neill, J. Robert, HuiSong Pak, Erola Pairo‐Castineira, et al.. (2017). Quantitative Shotgun Proteomics Unveils Candidate Novel Esophageal Adenocarcinoma (EAC)-specific Proteins. Molecular & Cellular Proteomics. 16(6). 1138–1150. 16 indexed citations
3.
Noble, Fergus, Rob F. Walker, Richard Turkington, et al.. (2016). A multicentre cohort study to redefine and validate pathological assessment of response to neoadjuvant therapy in treated oesophagogastric adenocarcinoma. European Journal of Surgical Oncology. 42(11). S252–S252. 1 indexed citations
4.
Blackmur, James P., Fiona A. Chapman, Christopher Bellamy, et al.. (2013). Anti-TNF-  therapy for renal amyloid as a complication of Crohn's disease. QJM. 107(1). 57–59. 7 indexed citations
5.
Bulusu, V.R., Helen Hatcher, Richard Hardwick, et al.. (2013). Ten-year prospective experience of gastrointestinal stromal tumors (GISTS) from the Cambridge GIST Study Group, United Kingdom.. Journal of Clinical Oncology. 31(15_suppl). 10541–10541. 1 indexed citations
7.
Peters, Christopher J., Jonathan Rees, Richard Hardwick, et al.. (2010). A 4-Gene Signature Predicts Survival of Patients With Resected Adenocarcinoma of the Esophagus, Junction, and Gastric Cardia. Gastroenterology. 139(6). 1995–2004.e15. 121 indexed citations
8.
Brais, Rebecca, Anne Lavergne‐Slove, Karen Payne, et al.. (2009). Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease. Gut. 59(4). 452–460. 46 indexed citations
9.
Barber, M. D., Adele Murrell, Yoko Itō, et al.. (2008). Mechanisms and sequelae of E‐cadherin silencing in hereditary diffuse gastric cancer. The Journal of Pathology. 216(3). 295–306. 98 indexed citations
11.
Bulusu, V.R., Catherine Jephcott, Natalie Cook, et al.. (2007). RECIST and Choi criteria for response assessment (RA) in patients with inoperable and metastatic gastrointestinal stromal tumours (GISTs) on imatinib mesylate. Cambridge GIST study group experience. Journal of Clinical Oncology. 25(18_suppl). 10019–10019. 5 indexed citations
12.
Chang, Chung‐Liang, Pierre Lao-Sirieix, Vicki Save, et al.. (2006). Retinoic acid-induced glandular differentiation of the oesophagus. Gut. 56(7). 906–917. 50 indexed citations
13.
Bulusu, V.R., Richard Hardwick, Nicholas Carroll, et al.. (2005). A review of the surgical management of metastatic gastrointestinal stromal tumours (GISTs) on imatinib mesylate (Glivec™). International Journal of Surgery. 3(3). 206–212. 22 indexed citations
14.
Save, Vicki, Peter A. Hall, & Philip J. Coates. (2004). Detecting and Quantifying Apoptosis in Tissue Sections. Humana Press eBooks. 282. 67–84. 6 indexed citations
15.
Save, Vicki, Philip J. Coates, & Peter A. Hall. (2003). Analysis of Apoptosis in Tissue Sections. Humana Press eBooks. 174. 347–359. 3 indexed citations
16.
Wong, Newton A C S, Rowan D. Young, Roger D. G. Malcomson, et al.. (2003). Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology. 43(2). 118–126. 134 indexed citations
17.
Campbell, Sandra J., et al.. (1998). An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth-regulated cross-reacting species p170. The Journal of Pathology. 186(3). 254–261. 10 indexed citations
18.
Campbell, Sandra J., et al.. (1998). An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth‐regulated cross‐reacting species p170. The Journal of Pathology. 186(3). 254–261. 1 indexed citations
19.
Midgley, Carol, Susan M. White, Rachel Howitt, et al.. (1997). APC EXPRESSION IN NORMAL HUMAN TISSUES. The Journal of Pathology. 181(4). 426–433. 5 indexed citations
20.
Midgley, Carol, Susan M. White, Rachel Howitt, et al.. (1997). APC EXPRESSION IN NORMAL HUMAN TISSUES. The Journal of Pathology. 181(4). 426–433. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026